Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Common Equity: 2009-2025

Historic Common Equity for Evotec SE (EVO) over the last 2 years, with Mar 2025 value amounting to $959,467.

  • Evotec SE's Common Equity was N/A to $959,467 in Q1 2025 from the same period last year, while for Mar 2025 it was $959,467, marking a year-over-year change of. This contributed to the annual value of $1.0 billion for FY2024, which is 15.53% down from last year.
  • Evotec SE's Common Equity amounted to $959,467 in Q1 2025, which was down 99.91% from $1.0 billion recorded in Q4 2024.
  • Evotec SE's 5-year Common Equity high stood at $1.6 billion for Q4 2021, and its period low was $959,467 during Q1 2025.
  • For the 3-year period, Evotec SE's Common Equity averaged around $741.3 million, with its median value being $1.0 billion (2024).
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 82.46% in 2021, then fell by 23.15% in 2022.
  • Over the past 5 years, Evotec SE's Common Equity (Quarterly) stood at $1.6 billion in 2021, then fell by 23.15% to $1.2 billion in 2022, then declined by 0.52% to $1.2 billion in 2023, then dropped by 15.53% to $1.0 billion in 2024, then reached $959,467 in 2025.
  • Its Common Equity stands at $959,467 for Q1 2025, versus $1.0 billion for Q4 2024 and $1.2 billion for Q4 2023.